These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9807950)

  • 1. The gallstone story.
    Dowling RH
    Ulster Med J; 1998 Jun; 67 Suppl 1(Suppl 1):20-4. PubMed ID: 9807950
    [No Abstract]   [Full Text] [Related]  

  • 2. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.
    Azzaroli F; Mazzella G; Mazzeo C; Simoni P; Festi D; Colecchia A; Montagnani M; Martino C; Villanova N; Roda A; Roda E
    Am J Gastroenterol; 1999 Sep; 94(9):2453-9. PubMed ID: 10484008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effects of dai-chai-hu-tang (dai-saiko-to) extract on supersaturated bile formation in cholesterol gallstone disease.
    Shoda J; Matsuzaki Y; Tanaka N; Miyamoto J; Osuga T
    Am J Gastroenterol; 1996 Apr; 91(4):828-30. PubMed ID: 8677979
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolic consequences of slow colonic transit.
    Lewis SJ; Heaton KW
    Am J Gastroenterol; 1999 Aug; 94(8):2010-6. PubMed ID: 10445521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constipation: is it a risk factor for cholesterol gallstones?
    Watkins JL; Wiley TE; Layden TJ
    Hepatology; 1993 Aug; 18(2):457-8. PubMed ID: 8340076
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone.
    Hasegawa K; Terada S; Kubota K; Itakura H; Imamura H; Ohnishi S; Aoki T; Ijichi M; Saiura A; Makuuchi M
    Am J Gastroenterol; 2003 Jul; 98(7):1605-9. PubMed ID: 12873586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity, biliary lipids, and gallstones in obese subjects.
    Chuang CZ; Martin LF; LeGardeur BY; Lopez A
    Am J Gastroenterol; 2001 Jun; 96(6):1860-5. PubMed ID: 11419840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients.
    Miquel JF; Van Der Putten J; Pimentel F; Mok KS; Groen AK
    Hepatology; 2001 Feb; 33(2):328-32. PubMed ID: 11172333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol gallstone pathogenesis].
    Méndez N; Uribe M; Jessurun J; Uscanga L
    Rev Invest Clin; 1990 Jul; 42 Suppl():53-7. PubMed ID: 19256135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of bowel movement frequency and use of laxatives with the occurrence of symptomatic gallstone disease in a prospective study of women.
    Dukas L; Leitzmann MF; Willett WC; Colditz GA; Giovannucci EL
    Am J Gastroenterol; 2001 Mar; 96(3):715-21. PubMed ID: 11280540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pigment gallstone formation in canines after total colectomy: preliminary report].
    Chijiiwa K; Nakahara S; Hotokezaka M; Noshiro H; Iwamoto T; Mibu R
    Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):94. PubMed ID: 8437557
    [No Abstract]   [Full Text] [Related]  

  • 12. [How is a cholesterol gallstone formed?].
    Erlinger S
    Gastroenterol Clin Biol; 1994; 18(11):984-7. PubMed ID: 7705586
    [No Abstract]   [Full Text] [Related]  

  • 13. American Gastroenterological Association. Gallstone disease: physicochemical research joins empirical surgery.
    Hofmann AF
    Gastroenterology; 1997 Jul; 113(1):341-4. PubMed ID: 9207296
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.
    Portincasa P; Moschetta A; Calamita G; Margari A; Palasciano G
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):67-81. PubMed ID: 12570727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
    Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
    Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: epidemiology of gall-bladder disease--role of intestinal transit.
    Heaton KW
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():9-13. PubMed ID: 10902996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New quantitative trait loci that contribute to cholesterol gallstone formation detected in an intercross of CAST/Ei and 129S1/SvImJ inbred mice.
    Lyons MA; Wittenburg H; Li R; Walsh KA; Leonard MR; Churchill GA; Carey MC; Paigen B
    Physiol Genomics; 2003 Aug; 14(3):225-39. PubMed ID: 12837957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous determination of eight kinds of conjunct bile acids in human bile by R-HPLC].
    Dai Z; Tan G; Qian K; Chen X
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):360-2. PubMed ID: 9868099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of mevalonate and 7 alpha-hydroxy-4-cholestene-3-one in cholesterol gallstone disease and their etiological significance.
    Shoda J; He BF; Tanaka N; Matzuzaki Y; Osuga T
    J Gastroenterol; 1994 Feb; 29(1):94. PubMed ID: 8199704
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered gallbladder bile acidification with long-term total parenteral nutrition.
    Dawes LG; Greiner M; Joehl RJ
    J Surg Res; 1999 Jan; 81(1):21-6. PubMed ID: 9889052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.